ST Pharm Co.Ltd Cash Flow Quality Index
ST Pharm Co.Ltd cash flow quality index. ST Pharm Co.Ltd (237690) has a Cash Flow Quality Index of -0.68x as of December 2025. Operating cash flow of ₩-21.16 Billion is below net income of ₩30.95 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore 237690 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of ST Pharm Co.Ltd (2015–2025)
Cash flow quality index of ST Pharm Co.Ltd from 2015 to 2025. Historical Cash Flow Quality Index for ST Pharm Co.Ltd across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. See ST Pharm Co.Ltd balance sheet quality to measure how much of total assets are equity-financed.
ST Pharm Co.Ltd Cash Flow Quality Index by Year (2015–2025)
ST Pharm Co.Ltd cash flow quality index by year from 2015 to 2025. Year-by-year earnings quality comparison for ST Pharm Co.Ltd. For the full cash flow conversion analysis, see ST Pharm Co.Ltd operating cash flow efficiency.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.25x | ₩13.99 Billion | ₩54.99 Billion | ▼ -94.4% |
| 2024 | 4.56x | ₩109.45 Billion | ₩24.02 Billion | ▲ +6049.4% |
| 2023 | 0.07x | ₩1.30 Billion | ₩17.52 Billion | ▼ -80.1% |
| 2022 | 0.37x | ₩7.03 Billion | ₩18.85 Billion | ▼ -75.8% |
| 2021 | 1.54x | ₩7.27 Billion | ₩4.71 Billion | ▲ +27.5% |
| 2017 | 1.21x | ₩54.44 Billion | ₩45.00 Billion | ▲ +46.4% |
| 2016 | 0.83x | ₩50.78 Billion | ₩61.43 Billion | ▼ -41.9% |
| 2015 | 1.42x | ₩35.82 Billion | ₩25.19 Billion | — |